about
Insights into the pathogenesis of Langerhans cell histiocytosis: the development of targeted therapiesLangerhans cell histiocytosis in children: from the bench to bedside for an updated therapy.Isolated Langerhans cell histiocytosis of the sublingual gland in an adult.Histological and immunohistochemical studies on primary intracranial canine histiocytic sarcomas.The potential of ixazomib, a second-generation proteasome inhibitor, in the treatment of multiple myeloma.Safety of proteasome inhibitors for treatment of multiple myeloma.Management of adverse events induced by next-generation immunomodulatory drug and proteasome inhibitors in multiple myeloma.Bone Langerhans cell histiocytosis with pulmonary involvement in an adult non-smoker: A case report and brief review of the literature.Management of eosinophilic granuloma in pediatric patients: surgical intervention and surgery combined with postoperative radiotherapy and/or chemotherapy.Safety of ixazomib for the treatment of multiple myeloma.Circulating cell-free BRAFV600E as a biomarker in children with Langerhans cell histiocytosis.Mediastinal Mass with Hyper-eosinophilia in a Young Boy -A Diagnostic Dilemma.Salvage treatment of relapsed/refractory LCHA rare case of CD1a-negative Langerhans cell histiocytosis of the central nervous system in a child.Evaluation and treatment of Langerhans cell histiocytosis patients with central nervous system abnormalities: Current views and new vistas.RAF/MEK/extracellular signal-related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesions.Efficacy of intermediate-dose cytarabine in central nervous system-relapsed wild-type BRAF Erdheim-Chester disease.Adult disseminated Langerhans cell histiocytosis: incidence, racial disparities and long-term outcomes.The multiple faces of Langerhans cell histiocytosis in childhood: A gentle reminder.Oral manifestation of Langerhans cell histiocytosis: a case report.V600E mutation detected in a case of Rosai-Dorfman diseaseAltered Populations of Unconventional T Cell Lineages in Patients with Langerhans Cell Histiocytosis
P2860
Q28071258-1364F5A1-8620-4B07-A9F0-3A38BD81032CQ34515611-55823074-43F4-46B7-99A7-1B2B825DAA8EQ36375615-11AF77C4-A71C-4A86-8AEF-DA516D3E96AAQ36919353-ABA10805-F155-47FA-AEF0-BA2DB4C29E32Q38685108-0617E4F2-2752-4964-BC8F-A6DFB37F3B5FQ39007504-58DFF75C-7A29-4DC7-8F6C-5A3929346066Q39022303-3A459223-2FA5-4254-A94A-5E1BB1647747Q39103762-8A4F53E1-1987-481B-8378-5BA8DE6817B6Q39159111-0E504E5C-809D-477B-B7C3-9EACEADC1E82Q39404809-D413F855-D765-4809-A982-2518BD7EDC84Q40464058-B26047DF-D1B9-4F3D-A309-BE5D292B7F64Q41072257-6F834AFC-1EED-4421-9CDC-925F9846E62EQ42195584-96720C26-A7A7-4CBD-9C89-D2AEF8A1EE46Q42279557-E6CF9C02-F821-4E25-A8BA-0003E1F6F262Q42515742-23FE4C70-E073-4774-ABBF-EA698ADFEF18Q47269284-52850D90-E676-4F5A-93F2-AD77D833F50AQ48198264-438F38BF-2B7D-40E4-AF51-B7E8413B6E2AQ48218706-A3084472-B35B-4E04-9846-9D47CFD6B8A2Q50282367-56E8BEFE-0372-4750-8604-37FCB835F69EQ55405945-7B0D929E-DAD6-43D8-9A85-FBE489EF39B6Q57723954-633FA176-3E94-4894-96E7-94CC578D681AQ58602623-6211163D-819C-4336-9C2D-BD6B6DFAFDC3
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
How I treat Langerhans cell histiocytosis.
@ast
How I treat Langerhans cell histiocytosis.
@en
type
label
How I treat Langerhans cell histiocytosis.
@ast
How I treat Langerhans cell histiocytosis.
@en
prefLabel
How I treat Langerhans cell histiocytosis.
@ast
How I treat Langerhans cell histiocytosis.
@en
P2860
P1433
P1476
How I treat Langerhans cell histiocytosis.
@en
P2093
Carl E Allen
P2860
P356
10.1182/BLOOD-2014-12-569301
P407
P577
2015-03-31T00:00:00Z